We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BLOOMS METFORMIN XR (Medreich Australia Pty Ltd)
Product name
BLOOMS METFORMIN XR
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
127 (255 working days)
Active ingredients
Metformin hydrochloride
Registration type
New generic medicine
Indication
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
BLOOMS METFORMIN XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.